Hospital surgical volume should be considered when judging value of procedures

May 5, 2013

The volume of cases performed at an institution each year has a direct effect on the outcome of surgical procedures, and should always be considered when looking at the benefits of a technique, according to a team of researchers at Henry Ford Hospital in Detroit.

Those conclusions will be presented May 5 at the annual meeting of the American Urological Association in San Diego.

The starting point of the study was the rapid increase in the use of to assist in radical prostatectomy, in which the entire and some surrounding tissue are removed to treat prostate cancer.

"This has happened in spite of a lack of randomized controlled studies to measure the superiority of robot-assisted radical prostatectomy, or RARP, over traditional open surgery to treat ," says Jesse D. Sammon, D.O., a researcher at Henry Ford's Vattikuti Urology Institute and lead author of the study.

"There have been some studies recently that suggested an advantage for RARP in terms of complication rates from the time a patient is admitted for surgery, through the operation itself and until time of discharge from the hospital."

Dr. Sammon continues: "But these studies didn't take into account the relationship between and the volume of surgery performed in a given institution. We set out to fill that void while comparing outcomes for RARP and open radical , or ORP."

Tapping data from the Nationwide Inpatient Sample – a set of databases maintained for researchers and policymakers to find and address trends in U.S. health care – the Henry Ford researchers identified 77,616 men who underwent in 2009. Of them, nearly 64 percent had RARP and about 36 percent had ORP.

The study then compared rates of , complications during and after surgery, prolonged length of hospital stay, elevated and mortality within the test group.

"Overall, RARP patients experienced lower complication rates than those treated with ORP," Dr. Sammon says. "However, the picture changed when we factored in whether the procedures were done at very high-volume medical centers or low-volume institutions."

Low-volume centers averaged 26.2 cases of RARP and 5.2 of ORP, while the highest volume centers averaged nearly 579 RARP cases and 150 ORP cases per year.

When these caseloads were taken into account, the researchers found that among equivalent volumes, RARP results were generally favorable; ORP, however, at very high-volume centers, had lower complication rates after surgery and comparable rates of blood transfusions relative to RARP at low-volume centers.

"So, regardless of the approach – whether RARP or ORP – low-volume institutions experienced inferior outcomes when compared to the highest volume centers," Dr. Sammon says.

Explore further: Fewer complications, better outcomes with robot-assisted prostate cancer surgery

Related Stories

Fewer complications, better outcomes with robot-assisted prostate cancer surgery

April 24, 2012
Robot-assisted surgery is now both more common and far more successful than radical "open" surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue ...

Robotic-assisted prostate cancer surgery drives up costs

May 23, 2012
In one of the most comprehensive analyses to date of the cost of robotic-assisted, laparoscopic surgery for prostate cancer, researchers at UPMC found that this now-dominant surgical approach is significantly more costly ...

Researchers find anatomic differences after robotic-assisted radical prostatectomy

April 11, 2011
Researchers from Boston University School of Medicine (BUSM) have concluded that the anatomy of the pelvis following robotic-assisted radical prostatectomy

Prostate cancer surgery better at teaching hospitals

November 7, 2011
Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study led by researchers at Henry ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.